Biomet Spinal Product Sales Investigated
The U.S. attorney's offices in Massachusetts and West Virginia are investigating Biomet, a leading orthopedic device manufacturer, for improper sales, promotion and billing by its spinal device unit, according to a report by the Wall Street Journal.
Biomet recently reported the investigations into the company's EBI unit, which makes electric stimulators to increase bone regeneration following spine surgery, to the Securities and Exchange Commission,
Recently, unsealed lawsuits in the states allege that Biomet promoted the off-label use of its spine stimulation devices, which resulted in fraudulent Medicare and Medicaid billing. Biomet denies the allegations.
Read the Wall Street Journal's report on the Biomet spinal product investigations.
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
Latest Articles
- ASC Industry Leader to Know: Senior Vice President of Access MediQuip Greg Lueck
- National Medical Billing Services Founder Lisa Rock Speaks on Optimizing Managed Care Contracts
- Houston Surgery Center Now Offers Cleft Lip & Palate Surgical Treatment
- 12 Hospitals Awarded for Eliminating Healthcare-Associated Infections
- ASC Industry Leader to Know: Jimmy St. Louis of Advanced Healthcare Partners
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,417.21 Trade time:3:17PM EDT Value change:▼85.60 (-0.68%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,826.76 Trade time:3:17PM EDT Value change:▼12.32 (-0.43%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,309.29 Trade time:3:17PM EDT Value change:▼7.34 (-0.56%)Channels
